In this study, we demonstrate that LncRNA-SERB could promote RCC VM formation and invasion via altering the LncRNA-SERB/ERβ/ZEB1 signals and targeting these newly identified signals may help physicians to develop a new therapy to better suppress the RCC progression. The gene discussed is ESR2; the disease is renal cell carcinoma.